×

Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimers disease

  • US 10,457,670 B2
  • Filed: 12/04/2017
  • Issued: 10/29/2019
  • Est. Priority Date: 04/23/2014
  • Status: Active Grant
First Claim
Patent Images

1. A method for a treatment of Alzheimer'"'"'s disease, schizophrenia, cognitive impairment associated with schizophrenia, pain, sleep disorder, Parkinson'"'"'s disease dementia, Parkinson'"'"'s disease, or dementia with Lewy bodies, in a mammal, which comprises administering to the mammal an effective amount of a compound represented by formula (I) below:

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×